Frontiers in Cardiovascular Medicine (Sep 2021)

The Utility of Advanced Cardiovascular Imaging in Cancer Patients—When, Why, How, and the Latest Developments

  • Christopher Yu,
  • Christopher Yu,
  • Faraz Pathan,
  • Faraz Pathan,
  • Timothy C. Tan,
  • Timothy C. Tan,
  • Kazuaki Negishi,
  • Kazuaki Negishi

DOI
https://doi.org/10.3389/fcvm.2021.728215
Journal volume & issue
Vol. 8

Abstract

Read online

Cardio-oncology encompasses the risk stratification, prognostication, identification and management of cancer therapeutics related cardiac dysfunction (CTRCD). Cardiovascular imaging (CVI) plays a significant role in each of these scenarios and has broadened from predominantly quantifying left ventricular function (specifically ejection fraction) to the identification of earlier bio-signatures of CTRCD. Recent data also demonstrate the impact of chemotherapy on the right ventricle, left atrium and pericardium and highlight a possible role for CVI in the identification of CTRCD through tissue characterization and assessment of these cardiac chambers. This review aims to provide a contemporary perspective on the role of multi-modal advanced cardiac imaging in cardio-oncology.

Keywords